Cargando…
Prolyl hydroxylation by EglN2 destabilizes FOXO3a by blocking its interaction with the USP9x deubiquitinase
The three EglN prolyl hydroxylases (EglN1, EglN2, and EglN3) regulate the stability of the HIF transcription factor. We recently showed that loss of EglN2, however, also leads to down-regulation of Cyclin D1 and decreased cell proliferation in a HIF-independent manner. Here we report that EglN2 can...
Autores principales: | Zheng, Xingnan, Zhai, Bo, Koivunen, Peppi, Shin, Sandra J., Lu, Gang, Liu, Jiayun, Geisen, Christoph, Chakraborty, Abhishek A., Moslehi, Javid J., Smalley, David M., Wei, Xin, Chen, Xian, Chen, Zhengming, Beres, Justine M., Zhang, Jing, Tsao, Jen Lan, Brenner, Mitchell C., Zhang, Yuqing, Fan, Cheng, DePinho, Ronald A., Paik, Jihye, Gygi, Steven P., Kaelin, William G., Zhang, Qing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4083087/ https://www.ncbi.nlm.nih.gov/pubmed/24990963 http://dx.doi.org/10.1101/gad.242131.114 |
Ejemplares similares
-
Transformation by the R Enantiomer of 2-Hydroxyglutarate Linked to EglN Activation
por: Koivunen, Peppi, et al.
Publicado: (2012) -
EglN2 positively regulates mitochondrial function in breast cancer
por: Zhang, Jing, et al.
Publicado: (2015) -
EglN2 contributes to triple negative breast tumorigenesis by functioning as a substrate for the FBW7 tumor suppressor
por: Takada, Mamoru, et al.
Publicado: (2016) -
A mitochondrial EglN1‐AMPKα axis drives breast cancer progression by enhancing metabolic adaptation to hypoxic stress
por: Jiang, Weiwei, et al.
Publicado: (2023) -
Mutation analysis of HIF prolyl hydroxylases (PHD/EGLN) in individuals with features of phaeochromocytoma and renal cell carcinoma susceptibility
por: Astuti, Dewi, et al.
Publicado: (2011)